title: Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes--Authors' reply.
authors.affiliation: Diabetes Trials Unit, Churchill Hospital, University of Oxford, Oxford, Headington OX3 7LJ, UK. Electronic address: rury.holman@dtu.ox.ac.uk.
authors.forename: Rury R
authors.initials: RR
authors.lastname: Holman
authors.affiliation: Diabetes Trials Unit, Churchill Hospital, University of Oxford, Oxford, Headington OX3 7LJ, UK; Division of Endocrinology and Metabolism, Medical University of Graz, Graz, Austria.
authors.forename: Harald
authors.initials: H
authors.lastname: Sourij
authors.affiliation: Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
authors.forename: Robert M
authors.initials: RM
authors.lastname: Califf
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents